Decibel Therapeutics

About:

Decibel Therapeutics is a hearing company focused on discovering and developing new medicines to protect, repair, and restore hearing.

Website: http://decibeltx.com

Twitter/X: decibeltx

Top Investors: BlackRock, Google Ventures, Bessemer Venture Partners, OrbiMed, Samsara BioCapital

Description:

Decibel Therapeutics is a developer of hearing disorder therapeutics intended to protect, repair and restore hearing. The company's therapeutics have provided insights into the link between hearing dysfunction and inner ear pathology and it has capabilities to encompass animal models, drug delivery to the inner ear, imaging, inner ear PK/PD modeling and measurement, bioinformatics, genetics and target identification, enabling patients to experience hearing loss therapies with different forms of hearing disorders for their recovery.

Total Funding Amount:

$189M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Cambridge, Massachusetts, United States

Founded Date:

2015-01-01

Contact Email:

info(AT)decibeltx.com

Founders:

Gabriel Corfas, M. Charles Liberman

Number of Employees:

51-100

Last Funding Date:

2020-11-09

IPO Status:

Public

Industries:

© 2025 bioDAO.ai